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Consumption of food or feed contaminated with fumonisin B1 (FB1), a mycotoxin 
produced by Fusarium verticillioides, leads to disease in humans and animals. This 
mycotoxin reduces the efficiency of parenteral vaccinations, indicating that ingestion of 
FB1-contaminated food suppresses the systemic immune system. This study was 
conducted to elucidate the mechanisms by which FB1 exerts its immunosuppressive 
effects on the intestinal immune system. Piglets were used as a model species for humans 
since their gastrointestinal tracts are very similar both on an anatomical and physiological 
level. The animals were orally exposed to a low dose of FB1 (1 mg/kg body weight) for 
10 days which did not result in any clinical signs. However, when compared to control 
animals, FB1-exposed animals demonstrated a prolonged excretion of the porcine-specific 
enteropathogen F4+ enterotoxigenic E. coli (F4+ ETEC) following infection. Upon oral 
immunisation with purified F4 fimbriae, FB1 exposure reduced the intestinal antigen-
specific immune response as compared to control animals. Further analyses to elucidate 
the mechanisms behind these observations revealed a reduced expression of IL-12p40 
mRNA by intestinal immune cells. Since this cytokine is mainly secreted by antigen 
presenting cells, we analysed the effects of FB1 on small intestinal CD11R1+ lamina 
propria dendritic cells (LPDC). These CD11R1+ LPDC matured in response to 
stimulation with the ETEC-derived virulence factors, F4 fimbriae and flagellin, indicating 
that this intestinal DC subset is involved in the induction of protective immunity. 
However, in vivo exposure of piglets to FB1 impaired the functional maturation of F4 
fimbriae- and flagellin-stimulated CD11R1+ LPDC as evidenced by a decreased 
upregulation of MHCII and CD80/86 and a reduced T cell stimulatory capacity. These 
results indicate an FB1-mediated reduction of in vivo DC maturation and stress the need 
to reduce exposure of animals and humans to FB1 in order to enhance the efficacy of 
vaccination programs. 
 
